Reported Earnings • May 30
Full year 2026 earnings released: EPS: ₹6.72 (vs ₹6.45 in FY 2025) Full year 2026 results: EPS: ₹6.72 (up from ₹6.45 in FY 2025). Revenue: ₹7.12b (up 20% from FY 2025). Net income: ₹400.3m (up 27% from FY 2025). Profit margin: 5.6% (up from 5.3% in FY 2025). The increase in margin was driven by higher revenue. 공시 • May 22
Indogulf Cropsciences Limited to Report Q4, 2026 Results on May 28, 2026 Indogulf Cropsciences Limited announced that they will report Q4, 2026 results on May 28, 2026 Valuation Update With 7 Day Price Move • Apr 01
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹62.41, the stock trades at a trailing P/E ratio of 10.3x. Average trailing P/E is 19x in the Chemicals industry in India. New Risk • Feb 13
New major risk - Financial position The company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (currently running at an operating cash loss). Minor Risk Market cap is less than US$100m (₹4.47b market cap, or US$49.3m). Reported Earnings • Feb 12
Third quarter 2026 earnings released: EPS: ₹0.77 (vs ₹0.86 in 3Q 2025) Third quarter 2026 results: EPS: ₹0.77. Revenue: ₹1.19b (up 19% from 3Q 2025). Net income: ₹38.6m (up 5.6% from 3Q 2025). Profit margin: 3.3% (down from 3.7% in 3Q 2025). The decrease in margin was driven by higher expenses. 공시 • Feb 06
Indogulf Cropsciences Limited to Report Q3, 2026 Results on Feb 11, 2026 Indogulf Cropsciences Limited announced that they will report Q3, 2026 results on Feb 11, 2026 공시 • Nov 08
Indogulf Cropsciences Limited to Report Q2, 2026 Results on Nov 12, 2025 Indogulf Cropsciences Limited announced that they will report Q2, 2026 results on Nov 12, 2025 공시 • Sep 30
Indogulf Cropsciences Limited Appoints Snehal Kashyap as an Independent, Professional and Non- Executive Director Indogulf Cropsciences Limited announced the appointment of Mrs. Snehal Kashyap as an independent, professional and Non- executive Director. 공시 • Sep 03
Indogulf Cropsciences Limited, Annual General Meeting, Sep 29, 2025 Indogulf Cropsciences Limited, Annual General Meeting, Sep 29, 2025, at 13:00 Indian Standard Time. Valuation Update With 7 Day Price Move • Aug 22
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹115, the stock trades at a trailing P/E ratio of 21.4x. Average trailing P/E is 27x in the Chemicals industry in India. 공시 • Aug 09
Indogulf Cropsciences Limited to Report Q1, 2026 Results on Aug 13, 2025 Indogulf Cropsciences Limited announced that they will report Q1, 2026 results on Aug 13, 2025 공시 • Jul 21
Indogulf Cropsciences Limited to Report Fiscal Year 2025 Results on Jul 24, 2025 Indogulf Cropsciences Limited announced that they will report fiscal year 2025 results on Jul 24, 2025 New Risk • Jul 09
New major risk - Financial position The company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (₹6.51b market cap, or US$75.8m). 공시 • Jul 02
Indogulf Cropsciences Limited has completed an IPO in the amount of INR 2 billion. Indogulf Cropsciences Limited has completed an IPO in the amount of INR 2 billion.
Security Name: Equity Shares
Security Type: Common Stock
Securities Offered: 6,235,900
Price\Range: INR 111
Discount Per Security: INR 5.2392
Security Name: Equity Shares
Security Type: Common Stock
Securities Offered: 5,243,242
Price\Range: INR 111
Discount Per Security: INR 5.2392
Security Name: Equity Shares
Security Type: Common Stock
Securities Offered: 3,665,183
Price\Range: INR 111
Discount Per Security: INR 5.2392
Security Name: Equity Shares
Security Type: Common Stock
Securities Offered: 2,672,529
Price\Range: INR 111
Discount Per Security: INR 5.2392
Security Name: Equity Shares
Security Type: Common Stock
Securities Offered: 223,290
Price\Range: INR 100
Discount Per Security: INR 4.72
Transaction Features: Regulation S; Reserved Share Offering 
